Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-08-16 Purchase | 2021-08-17 09:11 am | Phio Pharmaceuticals Corp. | PHIO | Dispersyn Gerrit CEO | 6,000 | $1.63 | $9,780 | 95,281 (Direct) | View |
| 2021-03-04 Purchase | 2021-03-05 07:05 am | Phio Pharmaceuticals Corp. | PHIO | Dispersyn Gerrit CEO | 1,953 | $2.56 | $5,000 | 89,281 (Direct) | View |
| 2021-03-01 Purchase | 2021-03-03 9:05 pm | Phio Pharmaceuticals Corp. | PHIO | Ferrara Robert L Director | 682 | $3.15 | $2,148 | 13,000 (Direct) | View |
| 2021-03-01 Purchase | 2021-03-03 9:00 pm | Phio Pharmaceuticals Corp. | PHIO | Dispersyn Gerrit CEO | 2,500 | $3.03 | $7,575 | 87,328 (Direct) | View |
| 2020-08-19 Purchase | 2020-08-19 5:00 pm | Phio Pharmaceuticals Corp. | PHIO | Dispersyn Gerrit CEO | 2,000 | $2.5 | $5,000 | 16,377 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-10-01 Option Award | 2022-10-03 8:01 pm | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | Bitterman Robert J Director | 40,000 | $0 | 65,826 (Direct) | View |
| 2022-08-09 Option Award | 2022-09-26 7:00 pm | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | BRADFORD PATRICIA A Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-03-01 Tax Withholding | 2022-03-03 7:13 pm | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | Kontulis Caitlin VP | 4,011 | $0.821 | 103,815 (Direct) | View |
| 2022-03-01 Tax Withholding | 2022-03-03 7:12 pm | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | Dispersyn Gerrit CEO | 8,954 | $0.821 | 212,327 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-16 8:12 pm | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | Lockshin Curtis Director | 10,000 | $0 | 20,366 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-16 8:10 pm | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | Kontulis Caitlin VP | 68,000 | $0 | 107,826 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-16 8:08 pm | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | Freeman Jonathan E Director | 10,000 | $0 | 20,364 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-16 8:06 pm | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | Ferrara Robert L Director | 10,000 | $0 | 23,000 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-16 8:05 pm | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | Dorman H. Paul Director | 10,000 | $0 | 20,370 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-16 8:03 pm | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | Dispersyn Gerrit CEO | 126,000 | $0 | 221,281 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-16 8:01 pm | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | CAUWENBERGH GEERT Director | 10,000 | $0 | 32,822 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-16 7:59 pm | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | Bitterman Robert J Director | 10,000 | $0 | 25,826 (Direct) | View |
| 2021-03-01 Option Award | 2021-03-03 9:05 pm | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | CAUWENBERGH GEERT Director | 10,000 | $0 | 22,822 (Direct) | View |
| 2021-03-01 Option Award | 2021-03-03 9:05 pm | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | Dorman H. Paul Director | 10,000 | $0 | 10,370 (Direct) | View |
| 2021-03-01 Option Award | 2021-03-03 9:05 pm | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | Freeman Jonathan E Director | 10,000 | $0 | 10,364 (Direct) | View |
| 2021-03-01 Option Award | 2021-03-03 9:05 pm | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | Lockshin Curtis Director | 10,000 | $0 | 10,366 (Direct) | View |
| 2021-03-01 Option Award | 2021-03-03 9:05 pm | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | Bitterman Robert J Director | 10,000 | $0 | 15,826 (Direct) | View |
| 2021-03-01 Option Award | 2021-03-03 9:05 pm | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | Ferrara Robert L Director | 10,000 | $0 | 13,000 (Direct) | View |
| 2021-03-01 Option Award | 2021-03-03 9:00 pm | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | Dispersyn Gerrit CEO | 68,450 | $0 | 87,328 (Direct) | View |
| 2021-03-01 Option Award | 2021-03-03 9:00 pm | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | Kontulis Caitlin VP | 34,600 | $0 | 39,826 (Direct) | View |
| 2020-03-01 Tax Withholding | 2020-03-03 8:27 pm | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | Dispersyn Gerrit CEO | 673 | $2.93 | 14,628 (Direct) | View |
| 2019-11-18 Option Award | 2019-11-20 7:38 pm | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | Bitterman Robert J Director | 300,000 | $0.1 | 320,440 (Direct) | View |
| 2019-11-18 Option Award | 2019-11-20 7:35 pm | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | Dispersyn Gerrit CEO | 350,000 | $0.1 | 827,817 (Direct) | View |
| 2019-11-18 Option Award | 2019-11-20 7:32 pm | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | Kontulis Caitlin VP | 237,500 | $0.1 | 279,030 (Direct) | View |
| 2019-11-18 Option Award | 2019-11-20 7:27 pm | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | CAUWENBERGH GEERT Director | 225,000 | $0.1 | 705,291 (Direct) | View |
| 2019-11-18 Option Award | 2019-11-20 7:24 pm | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | Ferrara Robert L Director | 127,500 | $0.1 | 127,500 (Direct) | View |
| 2019-08-01 Tax Withholding | 2019-08-02 8:41 pm | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | CAUWENBERGH GEERT Director | 1,751 | $0.403 | 480,291 (Direct) | View |
| 2019-08-01 Tax Withholding | 2019-08-02 8:36 pm | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | Dispersyn Gerrit CEO | 1,236 | $0.403 | 477,817 (Direct) | View |
| 2019-08-01 Tax Withholding | 2019-08-02 8:34 pm | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | Kontulis Caitlin VP | 749 | $0.403 | 41,530 (Direct) | View |
| 2019-04-22 Option Award | 2019-04-24 8:25 pm | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | Barrett John A Chief Development Officer | 222,991 | $0 | 222,991 (Direct) | View |
| 2019-03-01 Option Award | 2019-03-05 9:01 pm | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | Dispersyn Gerrit CEO | 407,703 | $0 | 479,053 (Direct) | View |
| 2019-02-28 Option Award | 2019-03-01 09:24 am | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | CAUWENBERGH GEERT CEO | 152,415 | $0.3798 | 482,042 (Direct) | View |
| 2019-02-15 Option Award | 2019-02-19 08:54 am | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | CAUWENBERGH GEERT CEO | 22,279 | $0.3634 | 329,627 (Direct) | View |